logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ.

    Article - En anglais

    We calculated the short-term and long-term risks of developing cancer among 3,766 patients with a diagnosis of cutaneous melanoma in situ in Sweden from 1958 to 1992.

    In total, 393 patients developed a primary cancer at any site compared with an expected number of 177 [standardized incidence ratio (SIR)=2.2,95% confidence interval (Cl)=2.0-2.4]. Patients below 60 years of age at diagnosis had the highest SIR (2.7,95% Cl=2.3-3.2).

    The overall risks were similar between men and women.

    The highest risk was seen during the first year of follow-up, though the risk remained elevated also after 15 or more years of follow-up.

    For specific sites, the highest SIR was found for developing invasive cutaneous malignant melanoma (SIR=22.2).

    The risk of subsequent primary non-melanoma skin cancer was elevated 8-fold in men and almost 7-fold in women.

    An elevated risk was also found for female breast cancer (SIR=1.4).

    Especially among women, other sites with increased cancer risk (though not significant) were non-Hodgkin's lymphoma (SIR=1.9), multiple myeloma (3.2) and cancers of the colon (1.6) and pancreas (1.6).

    In conclusion, patients with melanoma In situ run a generally increased risk of developing primary cancers, especially cutaneous malignant melanoma and non-melanoma skin cancer.

    The increased long-term risk of cancer after diagnosis of melanoma in situ may be due to continuing carcinogenic exposure or to intrinsic tumor susceptibility.

    Mots-clés Pascal : Mélanome, Peau, Facteur risque, Tumeur maligne, Hémopathie maligne, Second cancer, Cancer in situ, Epidémiologie, Suède, Europe, Homme, Peau pathologie

    Mots-clés Pascal anglais : Melanoma, Skin, Risk factor, Malignant tumor, Malignant hemopathy, Second cancer, Carcinoma in situ, Epidemiology, Sweden, Europe, Human, Skin disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0494185

    Code Inist : 002B04B. Création : 22/03/2000.